Author

Nilasha Ghosh

Hospital for Special SurgeryORCID 0000-0002-8799-9309Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Alice HorisbergeriD· 1 shared Anne R. BassiD· 1 shared Deepak A. RaoiD· 1 shared Ifeoluwakiisi AdejooriniD· 1 shared Kathryne E. MarksiD· 1 shared Laura T. DonliniD· 1 shared Mehreen Elahee· 1 shared Michael Andrew PostowiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alice HorisbergerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pre-treatment naive T cells are associated with severe irAE following PD-1/CTLA4 checkpoint blockade for melanoma

Kathryne E. Marks, Alice Horisberger, Mehreen Elahee, Ifeoluwakiisi Adejoorin, Nilasha Ghosh, Michael Andrew Postow, Laura T. Donlin, Anne R. Bass, Deepak A. Rao

This study identifies pre-treatment naive CD4+ T cell abundance as a predictor of severe irAEs in patients receiving anti-PD-1/CTLA4 checkpoint inhibitor therapy for melanoma.

JCI Insight · Nov 25, 2025Peer-reviewedImmunology